158 related articles for article (PubMed ID: 2957614)
21. Hepatitis B vaccination in Ramathibodi health personnel 1986-1987.
Promjunyakul K; Limsuwan A
J Med Assoc Thai; 1989 Jul; 72 Suppl 2():23-5. PubMed ID: 2527940
[TBL] [Abstract][Full Text] [Related]
22. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
23. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
24. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
25. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
26. [Experience with anti-viral hepatitis B vaccine at an institution for handicapped children].
Biadaioli R; Losco D; Buonamici C; Mazzotta F; Di Pietro M; Ulivelli A
Minerva Pediatr; 1989 Jul; 41(7):375-8. PubMed ID: 2532299
[TBL] [Abstract][Full Text] [Related]
27. Engerix-B hepatitis B vaccine (recombinant)/Smith, Kline & French.
Swartz ML
Gastroenterol Nurs; 1991; 13(3):158-61. PubMed ID: 1825929
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
[TBL] [Abstract][Full Text] [Related]
30. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
31. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
32. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
33. A review of the long-term protection after hepatitis A and B vaccination.
Van Damme P; Van Herck K
Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
[TBL] [Abstract][Full Text] [Related]
34. [The hepatitis B vaccination campaign carried out from 1982 to 1984 using the Hevac B Pasteur vaccine among 6162 employees of Vaud hospitals].
Rossier P; Peitrequin R; Frei PC
Schweiz Med Wochenschr; 1987 Apr; 117(17):629-37. PubMed ID: 3589620
[TBL] [Abstract][Full Text] [Related]
35. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
36. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus infection.
Chang MH
Semin Fetal Neonatal Med; 2007 Jun; 12(3):160-7. PubMed ID: 17336170
[TBL] [Abstract][Full Text] [Related]
38. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.
Xu ZY; Liu CB; Francis DP; Purcell RH; Gun ZL; Duan SC; Chen RJ; Margolis HS; Huang CH; Maynard JE
Pediatrics; 1985 Nov; 76(5):713-8. PubMed ID: 3903646
[TBL] [Abstract][Full Text] [Related]
39. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
40. [Viral hepatitis and immunoprophylaxis].
Deinhardt F; Jilg W
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):134-45. PubMed ID: 2986380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
